However, no significant associations were found for other parameters, including gender, age, tumor location, TNM stage, tumor depth, lymph node metastasis, presence of lymphatic or perineural invasion, Ming classification, MLH1 expression and MSH2 expression in CD68+ or CD163+ TAMs. The gene discussed is MSH2; the disease is neoplasm.